Catalyst Wire Dossier Catalyst Wire Dossier

EXforge (valsartan/amlodipine)

valsartan and amlodipine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXforge (valsartan/amlodipine), covering 2012-06-01 to 2012-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients [Phase 4]

See pricing